poloxalene has been researched along with cardiovascular agents in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Islamov, BI; KobrinskiÄ, EM; Lubiako, AA; MaevskiÄ, EI; Vorob'ev, SI | 1 |
Deng, J; Li, WG; Ning, Q; Yu, DN; Zhou, Y | 1 |
2 other study(ies) available for poloxalene and cardiovascular agents
Article | Year |
---|---|
[Effect of proxanols on electromechanical coupling in the myocardium and their contribution to protection against ischemia by fluorocarbon emulsions].
Topics: Animals; Cardiovascular Agents; Coronary Disease; Emulsions; Fluorocarbons; Guinea Pigs; Heart; In Vitro Techniques; Myocardial Contraction; Poloxalene; Polyethylene Glycols; Rabbits; Ranidae; Rats | 1987 |
Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Capsules; Cardiovascular Agents; Cholesterol; Drug Delivery Systems; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Liposomes; Male; Particle Size; Permeability; Phosphatidylcholines; Poloxalene; Poloxamer; Rats, Sprague-Dawley | 2014 |